179 related articles for article (PubMed ID: 29285522)
1. Cannabidiol Does Not Convert to Δ
Wray L; Stott C; Jones N; Wright S
Cannabis Cannabinoid Res; 2017; 2(1):282-287. PubMed ID: 29285522
[No Abstract] [Full Text] [Related]
2. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
3. Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment.
Franz S; Herzog J; Skopp G; Musshoff F
Int J Legal Med; 2023 Jan; 137(1):79-87. PubMed ID: 36190564
[TBL] [Abstract][Full Text] [Related]
4. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
Stott CG; White L; Wright S; Wilbraham D; Guy GW
Eur J Clin Pharmacol; 2013 Apr; 69(4):825-34. PubMed ID: 23052407
[TBL] [Abstract][Full Text] [Related]
5. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol, ∆
Pigliasco F; Malaca S; Lo Faro AF; Tini A; Cangemi G; Cafaro A; Barco S; Riva A; Pisati A; Amadori E; Striano P; Tagliabracci A; Huestis MA; Busardò FP
Front Pharmacol; 2022; 13():1038754. PubMed ID: 36353497
[TBL] [Abstract][Full Text] [Related]
7. Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.
Merrick J; Lane B; Sebree T; Yaksh T; O'Neill C; Banks SL
Cannabis Cannabinoid Res; 2016; 1(1):102-112. PubMed ID: 28861485
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic Evaluation of a Cannabidiol Supplement in Horses.
Williams MR; Holbrook TC; Maxwell L; Croft CH; Ientile MM; Cliburn K
J Equine Vet Sci; 2022 Mar; 110():103842. PubMed ID: 34923070
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
Fernández-Trapero M; Pérez-Díaz C; Espejo-Porras F; de Lago E; Fernández-Ruiz J
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054131
[TBL] [Abstract][Full Text] [Related]
10. A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain.
Ahmed F; Torrens A; Mahler SV; Ferlenghi F; Huestis MA; Piomelli D
Cannabis Cannabinoid Res; 2024 Feb; 9(1):371-385. PubMed ID: 36367975
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic of two oral doses of a 1:20 THC:CBD
Lyons C; McEwan K; Munn-Patterson M; Vuong S; Alcorn J; Chicoine A
Front Vet Sci; 2024; 11():1352495. PubMed ID: 38585296
[TBL] [Abstract][Full Text] [Related]
12. Determination of Δ
Papoutsis I; Hatzidouka V; Ntoupa SP; Angelis A; Dona A; Sakelliadis E; Spiliopoulou C
Forensic Toxicol; 2024 Apr; ():. PubMed ID: 38592642
[TBL] [Abstract][Full Text] [Related]
13. Oral Cannabidiol Does Not Convert to Δ
Crippa JAS; Zuardi AW; Hallak JEC; Miyazawa B; Bernardo SA; Donaduzzi CM; Guzzi S; Favreto WAJ; Campos A; Queiroz MEC; Guimarães FS; da Rosa Zimmermann PM; Rechia LM; Jose Tondo Filho V; Brum Junior L
Cannabis Cannabinoid Res; 2020 Mar; 5(1):89-98. PubMed ID: 32322680
[No Abstract] [Full Text] [Related]
14. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
15. A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
Stott CG; White L; Wright S; Wilbraham D; Guy GW
Eur J Clin Pharmacol; 2013 May; 69(5):1135-47. PubMed ID: 23179176
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients.
Roslawski MJ; Remmel RP; Karanam A; Leppik IE; Marino SE; Birnbaum AK
Ther Drug Monit; 2019 Jun; 41(3):357-370. PubMed ID: 30520828
[TBL] [Abstract][Full Text] [Related]
17. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
18. A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers.
Stott C; White L; Wright S; Wilbraham D; Guy G
Springerplus; 2013 Dec; 2(1):236. PubMed ID: 23750331
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
Wakshlag JJ; Schwark WS; Deabold KA; Talsma BN; Cital S; Lyubimov A; Iqbal A; Zakharov A
Front Vet Sci; 2020; 7():505. PubMed ID: 33102539
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Variability of Oral Cannabidiol and Its Major Metabolites after Short-Term High-Dose Exposure in Healthy Subjects.
Zhang Q; Melchert PW; Markowitz JS
Med Cannabis Cannabinoids; 2024; 7(1):1-9. PubMed ID: 38292071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
